20x new peptides could be approved after the shutdown (LEAK?) This could $NOVO B (-1,63%)
$HIMS (-4,31%)
$LLY (-1,14%) benefit from this!
Hims delivers earnings on 3.11 and two questions from the community will be answered after the press release. I am curious to see which ones will be discussed. I am also very excited about many topics (ZAVA partnership, GLP, margins....)
In addition, Hims has not been able to hold the USD 60 mark 5 times this year, interesting for trading until the rocket ignites.
